These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32012197)
1. Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells. Luo Z; Farnham PJ PLoS One; 2020; 15(2):e0228590. PubMed ID: 32012197 [TBL] [Abstract][Full Text] [Related]
2. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells. Bijl JJ; van Oostveen JW; Walboomers JM; Brink AT; Vos W; Ossenkoppele GJ; Meijer CJ Leukemia; 1998 Nov; 12(11):1724-32. PubMed ID: 9823947 [TBL] [Abstract][Full Text] [Related]
3. The role of HOXC6 in prostate cancer development. Hamid AR; Hoogland AM; Smit F; Jannink S; van Rijt-van de Westerlo C; Jansen CF; van Leenders GJ; Verhaegh GW; Schalken JA Prostate; 2015 Dec; 75(16):1868-76. PubMed ID: 26310814 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. McCabe CD; Spyropoulos DD; Martin D; Moreno CS Cancer Res; 2008 Mar; 68(6):1988-96. PubMed ID: 18339881 [TBL] [Abstract][Full Text] [Related]
5. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Ramachandran S; Liu P; Young AN; Yin-Goen Q; Lim SD; Laycock N; Amin MB; Carney JK; Marshall FF; Petros JA; Moreno CS Oncogene; 2005 Jan; 24(1):188-98. PubMed ID: 15637592 [TBL] [Abstract][Full Text] [Related]
6. [Effect of human cytomegalovirus infection on the expression of hoxc4 and hoxc6 genes in the proliferation of lymphocytic progenitor cells]. Feng JQ; Liu WJ; Chen HY; Guo QL; Chen A; Chen SQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):141-5. PubMed ID: 19236766 [TBL] [Abstract][Full Text] [Related]
7. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue. Bijl J; van Oostveen JW; Kreike M; Rieger E; van der Raaij-Helmer LM; Walboomers JM; Corte G; Boncinelli E; van den Brule AJ; Meijer CJ Blood; 1996 Mar; 87(5):1737-45. PubMed ID: 8634419 [TBL] [Abstract][Full Text] [Related]
8. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Miller GJ; Miller HL; van Bokhoven A; Lambert JR; Werahera PN; Schirripa O; Lucia MS; Nordeen SK Cancer Res; 2003 Sep; 63(18):5879-88. PubMed ID: 14522913 [TBL] [Abstract][Full Text] [Related]
9. HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas. Bijl JJ; van Oostveen JW; Walboomers JM; Horstman A; van den Brule AJ; Willemze R; Meijer CJ Blood; 1997 Nov; 90(10):4116-25. PubMed ID: 9354682 [TBL] [Abstract][Full Text] [Related]
10. Zhou J; Yang X; Song P; Wang H; Wang X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305 [No Abstract] [Full Text] [Related]
11. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659 [TBL] [Abstract][Full Text] [Related]
12. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans. VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ Elife; 2020 Jun; 9():. PubMed ID: 32553107 [TBL] [Abstract][Full Text] [Related]
13. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer. Leyten GH; Hessels D; Smit FP; Jannink SA; de Jong H; Melchers WJ; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Schalken JA Clin Cancer Res; 2015 Jul; 21(13):3061-70. PubMed ID: 25788493 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of Wang MQ; Yin QY; Chen YR; Zhu SL Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593 [TBL] [Abstract][Full Text] [Related]
16. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer. Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677 [TBL] [Abstract][Full Text] [Related]
17. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
18. Identification of transcription factor co-regulators that drive prostate cancer progression. Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156 [TBL] [Abstract][Full Text] [Related]
19. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer. Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830 [TBL] [Abstract][Full Text] [Related]
20. HOXC6 promotes cervical cancer progression via regulation of Bcl-2. Wang Y; Wang C; Liu N; Hou J; Xiao W; Wang H FASEB J; 2019 Mar; 33(3):3901-3911. PubMed ID: 30509141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]